Skip to main content
Top
Published in: Lasers in Medical Science 7/2021

Open Access 01-09-2021 | Prostate Cancer | Original Article

Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate—a comparison of patients with lower urinary tract symptoms and urinary retention

Authors: Pawel Trotsenko, Christian Wetterauer, Philipp Grimsehl, Tilmann Möltgen, Susan Meierhans, Lukas Manka, Helge Seifert, Stephen Wyler, Maciej Kwiatkowski

Published in: Lasers in Medical Science | Issue 7/2021

Login to get access

Abstract

Holmium laser enucleation of the prostate (HoLEP) is a valid treatment option to relieve bladder outlet obstruction in patients with large prostate volumes (PV). Its efficacy, tolerability, and safety are comparable to the ones of other laser treatments of the prostate and resection techniques. However, safety and efficacy of HoLEP have not been compared between patients with and without preoperative urinary retention. We included 350 patients (mean age 71.2 years) who had undergone HoLEP due to lower urinary tract symptoms (LUTS) or urinary retention caused by prostatic hyperplasia. We evaluated the differences in peri- and postoperative outcomes and complications between patients with and patients without preoperative urinary retention. The mean PV was 115 cm3. PV was > 100 cm3 in 61.9% and < 100 cm3 in 38.1% of the patients. Perioperative complications occurred in 23 patients (6.6%), 15 of which (4.3%) required operative revision. We found no significant differences in terms of complication rates between patients with PV > 100 cm3 and patients with PV < 100 cm3. Mean catheterization-duration was 3.3 days. Preoperatively, 140 patients (40%) had a suprapubic or transurethral indwelling catheter; they did not differ from patients without preoperative catheter regarding postoperative catheter removal success rate, early postoperative complications, and functional outcomes. Prostate cancer was diagnosed in 43 patients (12.3%). Median postoperative PSA-decline was 6.1 ug/l (89.8% drop). HoLEP is a safe and effective treatment for patients with LUTS or urinary retention and large PV. PV > 100 cm3 was not associated with higher complication rates or successful catheter-removal. Furthermore, functional outcomes were independent of preoperative catheterization.
Literature
2.
go back to reference Gravas S, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C et al (2019) Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) Arnhem: EAU Guidelines Office Gravas S, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C et al (2019) Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) Arnhem: EAU Guidelines Office
26.
Metadata
Title
Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate—a comparison of patients with lower urinary tract symptoms and urinary retention
Authors
Pawel Trotsenko
Christian Wetterauer
Philipp Grimsehl
Tilmann Möltgen
Susan Meierhans
Lukas Manka
Helge Seifert
Stephen Wyler
Maciej Kwiatkowski
Publication date
01-09-2021
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 7/2021
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-020-03170-4

Other articles of this Issue 7/2021

Lasers in Medical Science 7/2021 Go to the issue